The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
VJVirtual | Managing myeloma in the COVID-19 era
COVID-19 has placed additional challenges in the management of multiple myeloma. Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, discusses how the biology of myeloma and it’s treatment can render patients with this disease vulnerable. Prof. Mohty goes on to discuss the measures that can be taken to minimize the increased risk patients with myeloma face. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
